,ug/ml), norfloxacin (2.0 ,ug/ml), ofloxacin (0.625 ,Ig/ml), cefpodoxime (2.0 ,ug/ml), cefotaxime (1.0 ,ig/ml), ceftazidime (0.25 ,Ig/mI), ceftizoxime (0.25 
of this survey, as evidenced by the MIC90s of ciprofloxacin (0.25 ,ug/ml), norfloxacin (2.0 ,ug/ml), ofloxacin (0.625 ,Ig/ml), cefpodoxime (2.0 ,ug/ml), cefotaxime (1.0 ,ig/ml), ceftazidime (0.25 ,Ig/mI), ceftizoxime (0.25 ,ug/ml), and ceftriaxone (0.06 ,ug/ml). To date, ceftriaxone resistance has not emerged, despite the widespread use of this antibiotic in the Philippines.
Changes in the antibiotic resistance patterns of Neisseria gonorrhoeae isolates in the Philippines have heralded the emergence of resistant isolates in the United States over the last decade (7, 16) . This geographic area continues to serve as a test ground for the emergence of antibiotic-resistant N. gonorrhoeae isolates because of antibiotic pressure consequent to the continuous use of inadequately dosed prophylactic antibiotics by those who are repeatedly infected and high endemic rates of gonococcal infections in prostitutes who live adjacent to military bases.
Penicillin-resistant N. gonorrhoeae isolates were first reported in the Philippines in 1965 to 1966 (7, 16) . As antibiotic therapy was altered in response to the demonstration of resistance to this agent and later to others, these changes were followed by the emergence of isolates resistant to the newer therapeutic regimens (1, 2, (4) (5) (6) 14) . Unfortunately, it also appears that once antibiotic resistance develops, it persists in the local reservoir, despite the substitution of unrelated antimicrobial agents in new antibiotic regimens (10) .
The present study was undertaken to reassess the antibiotic susceptibility of N. gonorrhoeae isolates in the Philippines and, in particular, to examine the possibility of emerging ceftriaxone resistance, since this antibiotic is currently used to treat all gonococcal infections in the area from which these isolittes were collected. Antibiotic stock solutions were prepared in reagent-grade water and frozen at -70°C. Serial twofold dilutions of the antibiotics were prepared in reagent-grade water on the day of use.
MATERIALS AND METHODS

Gonococcal
Antibiotic susceptibility testing. Antibiotic susceptibility testing was conducted as previously described (15) . Quality control organisms inoculated on each plate were Staphylococcus aureus ATCC 29213, S. aureus ATCC 25923, Enterococcus faecalis ATCC 29212, and Escherichia coli ATCC 25922. Subcultures were incubated in a humidified atmosphere of 5% CO2 for 24 h at 35°C. MICs were read as the lowest concentration of antibiotic that inhibited growth (11).
Statistical analysis. The effect of P-lactamase production on susceptibility to each drug was examined by chi-square analysis with Epilnfo Version 5.00 (Centers for Disease Control Epidemiology Program Office, Atlanta, Ga.). Significance was defined as P c 0.05. Data are presented sepa- rately for drugs for which 1-lactamase production was found to have a significant effect on susceptibility.
RESULTS
One hundred forty isolates were confirmed to be N. gonorrhoeae. Although no single drug was evaluated against all isolates (Table 1) , 3-lactamase was detected in 77 of 140 (55%) isolates and conferred resistance to penicillin (MIC, >2 jg/ml) in 76 of 77 (98%) (13). Thirty-two of 61 (52%) 3-lactamase-negative isolates also were penicillin resistant (P < 0.001) ( (P < 0.001) (Fig. 2) . Sixty-one percent (36 of 59) of 3-lactamase-negative and 17.3% (13 of 75) of 3-lactamase-positive isolates were resistant to cefmetazole (MIC, >8 ,ug/ml) (P < 0.001) (Fig. 3) . Thirty-two percent (24 of 75) of 3-lactamasepositive and 66% (40 of 60) of P-lactamase-negative isolates were resistant to tetracycline (MIC, .2 jig/ml) (P < 0.001) (Fig. 4) (8) . A few isolates were resistant to erythromycin, spectinomycin, trospectinomycin, cefoxitin, and cefuroxime, but the association with P-lactamase production was not significant (Fig. 5 to 9 ) (8, 9, 13). A single isolate was resistant to ciprofloxacin (MIC, .4 ,ug/ml) and was ,-lactamase negative (Fig. 10) (13) . None of the isolates tested was found to be resistant to cefotaxime, cefpodoxime, ceftazi- dime, ceftizoxime, ceftriaxone, norfloxacin, or ofloxacin ( Fig. 11 to 17) (8, 13) .
DISCUSSION
This survey revealed that established resistance to penicillin and other P-lactamase-susceptible antibiotics, tetracyclines, and erythromycin has continued at a high prevalance. The MICs for 90% of isolates (MIC90s) of penicillin G (>64 ,ug/ml), tetracycline (4 [±g/ml), and erythromycin (>4 ,ug/ml) were consistent with those reported in previous studies carried out in the Philippines (1, 2, 4, 10, 14) . Azlocillin, a ureidopenicillin, presented no advantage over penicillin G, since it too was susceptible to P-lactamase (12) . The r-lac- tamase-stable broad-spectrum cephalosporins were highly active against all or most of the strains and should each be effective at the usual preferred dose. The fluoroquinolones tested were effective against all or most of the strains in vitro and may represent a viable treatment option in the Philippines. Although no fluoroquinolone antibiotics have been officially recommended in the Philippines since the discontinuation of rosoxacin use by health department clinics several years prior to this study, the MIC90 of norfloxacin is now 16-fold higher than the MIC98 reported in 1982 data (3).
The uncontrolled availability of antibiotics has previously been cited as a confounding factor in the selection of a therapeutic regimen in and near Subic Bay and probably contributes significantly to the development and persistence of resistant strains (6) . Also of interest is the presence of a P-lactamase plasmid in 55% of all strains and chromosomally mediated resistance to penicillin in 57% of the 1-lactamasenegative strains as well. This fact probably reflects the ongoing practice by sexually active persons of continuously taking subtherapeutic doses of oral penicillins. Spectinomycin and the investigational drug trospectinomycin were active against greater than 90% of strains, but the overall level of resistance of susceptible strains is increasing. Spectinomycin (MICgo, 32 ,ug/ml) is probably useful in the treatment of those for whom ceftriaxone is contraindicated. The prevalence of resistance to spectinomycin has declined from 22% 
